Metastatic sarcomatoid renal cell carcinoma manifesting as a subcutaneous soft tissue mass.

about

Metastatic sarcomatoid renal cell carcinoma manifesting as a subcutaneous soft tissue mass.

Item

http://www.wikidata.org/entity/Q48181382

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Metastatic sarcomatoid renal c ...... subcutaneous soft tissue mass.

@en

Metastatic sarcomatoid renal c ...... subcutaneous soft tissue mass.

@nl

type

Item

label

Metastatic sarcomatoid renal c ...... subcutaneous soft tissue mass.

@en

Metastatic sarcomatoid renal c ...... subcutaneous soft tissue mass.

@nl

prefLabel

Metastatic sarcomatoid renal c ...... subcutaneous soft tissue mass.

@en

Metastatic sarcomatoid renal c ...... subcutaneous soft tissue mass.

@nl

P1476

Metastatic sarcomatoid renal c ...... subcutaneous soft tissue mass

@en

P2093

Kenneth A Iczkowski

http://www.w3.org/2001/XMLSchema#string

Olayemi Sokumbi

http://www.w3.org/2001/XMLSchema#string

P2860

PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study

Unsuspected metastases presenting as solitary soft tissue lesions: a fourteen-year review.

Distant soft tissue metastases: a series of 30 new patients and 91 cases from the literature.

Sarcomatoid renal cell carcinoma: a comprehensive review of the biology and current treatment strategies.

Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer.

Metastases to soft tissue: a review of 118 cases over a 30-year period.

PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison.

Diagnosing primary and metastatic renal cell carcinoma: the use of the monoclonal antibody 'Renal Cell Carcinoma Marker'.

Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma.

Combined p53 and MDM2 biomarker analysis shows a unique pattern of expression associated with poor prognosis in patients with renal cell carcinoma undergoing radical nephrectomy.

P304

874-877

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CUP.12998

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Valentina Logunova

P577

2017-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28675457

http://www.w3.org/2001/XMLSchema#string